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Lars K Poulsen1*, Gregory S Ladics2, Scott McClain3, Nancy G Doerrer4 and Ronald van Ree5Abstract
The scope of allergy risk is diverse considering the myriad ways in which protein allergenicity is affected by
physiochemical characteristics of proteins. The complexity created by the matrices of foods and the variability of
the human immune system add additional challenges to understanding the relationship between sensitization
potential and allergy disease. To address these and other issues, an April 2012 international symposium was
held in Prague, Czech Republic, to review and discuss the state-of-the-science of sensitizing properties of protein
allergens. The symposium, organized by the Protein Allergenicity Technical Committee of the International Life
Sciences Institute’s Health and Environmental Sciences Institute, featured presentations on current methods, test
systems, research trends, and unanswered questions in the field of protein sensitization. A diverse group of over
70 interdisciplinary scientists from academia, government, and industry participated in the symposium. Experts
provided overviews on known mechanisms by which proteins in food may cause sensitization, discussed experimental
models to predict protein sensitizing potential, and explored whether such experimental techniques may be
applicable in regulatory settings. Three accompanying reviews address critical factors and methods for assessing
allergic sensitization: 1) food-and protein-related factors; 2) host-specific factors and 3) screening methods, i.e.,
the ability of experimental models to predict the sensitizing potential of proteins and whether such models are
applicable within regulatory settings.
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The occurrence of food allergies is not evenly distributed
globally and demonstrates some striking fluctuations:
 Although clinicians and immunologists have noted
that good data from important parts of the world are
lacking, there appear to be major regional differences
in the prevalence of food allergy with variability in the
pattern of foods to which patients react.
 Infants, older children, and adults react to
different foods.
 There is some evidence that food allergy prevalence
may be increasing, i.e., a temporal change, in parallel
to the rise in inhalation allergies seen in many parts
of the world.* Correspondence: lkpallgy@mail.dk
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unless otherwise stated. Of the large variety of ingested food proteins,
it is a relatively small number that seem to act as
food allergens.
These paradoxes have been recognized for quite some
time [1]; however, in recent years, new biological research
has accumulated which may help explain these observa-
tions and use the knowledge to prevent or reduce the
occurrence of new sensitizations and food allergies.
In evaluating the safety of new proteins in the human
food chain, including the safety evaluation that precedes
the introduction of genetically modified organisms (GMO),
the predominant focus in relation to allergy has so far been
on the elicitation phase of the allergic response. Fewer
data and experimental models exist in relation to the
mechanisms of induction of the sensitization phase or its
prediction. To provide a state-of-the-science review, an
international symposium titled “Sensitizing Properties of
Proteins” was held in April 2012 in Prague, Czech Republic,
bringing together over 70 scientists from academia,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the Protein Allergenicity Technical Committee (PATC) of
the International Life Sciences Institute’s (ILSI) Health
and Environmental Sciences Institute (HESI). The purpose
of the symposium was to present data on the current state
of the science regarding the sensitizing properties of
proteins in relation to food allergy. Experts from various
disciplines and fields provided overviews on known mech-
anisms by which proteins in foods may cause sensitization.
Also discussed was the ability of experimental models to
predict the sensitizing potential of proteins and whether
such experimental techniques are applicable within
regulatory settings. Information and context from these
presentations are described in three accompanying
reviews [2-4]: 1) food-and protein-related factors; 2) host-
immune factors and 3) screening methods, i.e., the ability
of experimental models to predict the sensitizing potential
of proteins and whether such models are applicable within
regulatory settings. This summary focuses on how the
field of protein sensitization from food, including test
systems, has developed, and identifies the most recent
research trends and unanswered questions.
The process of sensitization to a food allergen represents
an interplay between host-immune factors, the food, and
the circumstances under which exposure takes place. It
may be assumed that when infants develop food allergy
to cow's milk protein after ingesting large amounts of
milk the route of sensitization is oral via the digestive
tract. On the other hand, it is well documented that a
large proportion of food allergies occurring in adults
and adolescents stems from cross-reactivity between
food proteins and allergens derived from pollen where
the route of sensitization is believed to be via inhal-
ation. For foods such as peanuts and other legumes,
fish, and shellfish, the route of sensitization is less clear
with transdermal and inhalation routes having been
suggested in addition to oral sensitization.
Food and protein-related factors
Recent years have seen a dramatic increase in knowledge
about food allergens, with detailed biochemical and bio-
physical characterization of the individual molecules [5].
The cloning and expression of purified protein allergens
have allowed for more extensive studies. One important
finding is the relative restriction of food allergens to a
small number of protein families. While this is good
news for using the existing knowledge base of allergens
to predict and prevent potential cross-reactions when
new proteins (genetically modified [GM] or conventional)
are introduced into the food chain, it does not explain
why these molecules become allergens. Developments in
this field comprise studies of other biological capacities
of the allergens, such as enzymatic (protease) activity
and activation of the innate immune system, as well asbroader approaches which focus on the whole food
including matrix effects by lipids and cell walls. On the
mechanistic level, an important factor is the immune
system, where leukocytes can be modulated by enzym-
atic cleavage of receptors such as CD23 or CD25, or by
activation of innate immune receptors such as Toll-like
receptors by lipids or carbohydrates. Also the mucosal
integrity may be at play, as some allergens with enzymatic
activity have been shown to interfere with tight junctions
and make the epithelium more susceptible to allergen
uptake. Finally, protease-activated receptors on the epithe-
lium may become stimulated initiating an inflammatory
reaction. The way a food is processed may alter its inter-
action both with the digestive processes and the immune
system with the gut microbiota as an intercalating factor.
This is exemplified by stabilization of peanut allergens
by roasting and the possible formation of new epitopes
via Maillard reactions, which may take place when sugars
bind to proteins under heat treatment.
While knowledge about allergens and triggers of the
immune system has improved, the lectures and discussions
during the symposium demonstrated that a clear hypoth-
esis does not yet exist to explain the geographical and
temporal variations in prevalence that food allergy epide-
miologists observe. Clinically relevant cross-reactions may
occur due to exposure to homologues of food allergens
to which a patient has previously been sensitized, but
apart from such reactions, it seems evident that a primary
sensitization requires an exposure to the food in question.
Having established this, however, there is little evidence
of a dose–response relationship between the amount of
ingested food and the risk of food allergy in individuals
or in societies as a whole.
The epidemiological data, on the other hand, suggest
that food allergies related to cross-reactive pollen allergens
may be related to certain climate zones and specific fauna
of a geographical region. Moreover, there may be some
weak relationships to prevalent foods in an area, but the
globalization of the food market tends to blur this effect.
See McClain et al. [2] for a more detailed discussion
on the role of food- and protein-related factors in aller-
gic sensitization.
Host-immune factors
From a clinical perspective, it is crucial to identify risk
factors in the individual. Previous diseases or co-morbidity
are important in this respect, and it is essential to study
the conditions by which an early IgE-sensitization to a
food allergen develops into clinical food allergy. Allergic
diseases have a strong genetic component, and recent
findings that the filaggrin mutation may be a risk factor
for the development of peanut allergy [6] marks a signifi-
cant step toward understanding the full picture of the
etiology of allergy. The apparent increase in food allergy
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the epigenetic regulation of the sensitization phase, a field
which has not been studied so far in detail. Studies of
elicitation of food allergies have addressed the importance
of digestion and absorption processes, exercise, and drugs
on these host-specific factors, but there is a strong need to
extend these studies to include the sensitization phase.
Detailed knowledge about the epithelial barrier and
antigen presenting cells, i.e., dendritic cell subtypes that
are specifically involved in the formation of Th2 cells
and ultimately IgE-antibody production, may help with
development of models that will predict allergenicity.
In this respect, it is also pertinent to mention that
quantitative knowledge of dose-sensitization relationships
is extremely limited, but it is likely that both low- and
high-dose tolerance induction may be relevant mecha-
nisms for explaining the fact that just a small percentage
of the population actually develops food allergy while
the rest are tolerant to exposure to the same foods and
protein allergens.
It was clear from symposium presentations that a
multidisciplinary effort is necessary to delineate the path-
way of allergic sensitization to a food allergen. Steps that
must be considered are: 1) the passage of the allergen
across the epithelium (in the airways or the digestive
system) or the skin; 2) the antigen presenting cells, i.e.,
dendritic cells; 3) the resulting meeting between dendritic
cells and T cells; and finally, 4) the cooperation between
the T-helper cell and the B cell.
See van Ree et al. [3] for a discussion of the complex
interplay between the allergen and the host in allergic
sensitization.
Screening methods
Because knowledge of the processes leading to sensitiza-
tion to food proteins is still quite fragmented, it is not
surprising that there is no ideal model for risk evaluation
of new proteins. In fact, a stable animal model or an
in vitro system which will predict the sensitizing prop-
erties of a protein does not exist. However, there are
interesting new developments in various research fields
such as 1) in silico prediction of allergenic epitopes, 2)
in vitro testing of stimulatory effects on the innate and
the adaptive immune system, and 3) refined animal
models where sensitization and reactions to clinical
challenges act as outcome parameters. While these models
may provide information about the mechanisms behind
sensitization, they currently do not have the necessary
robustness and credibility for regulatory purposes, nor
can they predict allergy outcomes for a population. To
fulfill such a scope, it would be necessary for models to
provide an improved differentiation between some of
today’s known food allergens and putative non-allergenic
food proteins.Several of the symposium presentations supported the
notion that allergy and sensitization are in many ways
different from more "classical" toxicology when it comes
to test systems. First, as discussed above, the absence
of an overwhelming theory of how sensitization takes
place makes the approach of reductionism, known
from other areas of biology and toxicology, difficult.
That is, for example, when mutagenesis is believed to
form an important step towards cancer, it makes sense
to investigate for mutagenicity. But what are the crucial
steps in sensitization? Other than identifying proteins that
are closely biochemically related to known allergens, there
is no clear consensus on risk parameters to characterize a
new protein as a potential allergen.
Secondly, the very features of the immune system (i.e.,
the IgE system is triggered by relatively low doses of
antigen combined with mast cell activation which is one
of the strongest physiological amplification systems)
make quantitative modeling of dose–response extremely
difficult and requires complex models. In this respect,
the symposium's focus on sensitization was helpful, but
also raised an important question about whether other
important biomarkers exist beyond specific IgE on the
way to becoming clinically allergic.
See Ladics et al. [4] for a discussion of screening
methods and models that have been evaluated to predict
protein sensitizing potential.
Towards a unified understanding of food allergy
development
In conclusion, while not establishing an overall mech-
anistic model of how food proteins may sensitize the
human immune system, the symposium did establish some
common challenges for predicting protein sensitization
including (a) exposure routes; (b) frequency and dose
of exposure; (c) dose–response relationships; (d) role of
digestion, food processing, and the food matrix; (e) role
of infection; (f ) role of the gut microbiota; (g) influence
of the structure and physicochemical properties of the
protein; and (h) the genetic background and physiology of
the consumers. The above models comprise a broad span
from biochemical high-throughput models (phage-display
technology or MHC-binding studies) over physiological
models such as simulated gastro-duodenal digestion or
synthetic organs to in vivo studies of allergenicity. The
overall consensus of symposium participants was that
screening models are extremely useful in the discovery
and research phases of understanding the mechanisms
of food allergy development. However, there are many
methodological shortcomings and limitations identified
with the current screening models (e.g., the lack of a
validated model that is predictive of protein allergen-
icity) which preclude their use for the safety assessment
of novel proteins, new foods, and GM crops.
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Agriculture Organization (FAO) sponsored one of the first
comprehensive attempts to set up a total risk evaluation of
GMO and allergenicity more than 10 years ago [7], many
of the features of the original model have been refined.
The discussion has now moved from looking only at
cross-reactivity to known allergens to the increased
expression of endogenous allergens and the main
theme of the symposium, i.e., the possibility of new
proteins - unrelated to hitherto known allergens - becom-
ing new allergens.
The 2012 symposium provided a forum to coalesce the
state-of-the-science around predicting how and when food
protein allergens initiate the allergic response. A generally
increased interest in food allergy safety from the public
has highlighted the need and benefits that will be gained
once it is more fully understood how to predict when a
protein may act as an allergen. As noted in existing regula-
tory safety guidance and numerous publications, allergy
safety still relies on an accumulation of characterization
studies rather than a single test (i.e., a weight-of-evidence
approach).
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